Muscular Dystrophy Trial, By Invitation
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
If you have Myotonic Dystrophy Type 2 (DM2):
- You are between 30 and 65 years old
- You have been diagnosed with DM1 or DM2 through genetic testing or by a doctor's assessment (if diagnosed by assessment only, a close blood relative must have had a positive genetic test)
- You have symptoms or signs of weakness in the muscles closest to the center of your body (such as hips or shoulders)
- You can walk on your own (using a cane or walking stick is fine)
- You are willing and able to give your written agreement to take part in the study
If you have Myotonic Dystrophy Type 1 (DM1):
- You are between 30 and 65 years old
- You have been diagnosed with adult-onset DM1 through genetic testing or by a doctor's assessment (if diagnosed by assessment only, a close blood relative must have had a positive genetic test)
- Your first symptoms began between the ages of 20 and 40
- You have symptoms or signs of weakness in the muscles farther from the center of your body (such as hands or feet) and muscle stiffness
- You can walk on your own (using a cane or walking stick is fine)
- You are willing and able to give your written agreement to take part in the study
If you are a Healthy Volunteer:
- You are between 30 and 65 years old
- You can walk on your own
- You are willing and able to give your written agreement to take part in the study
Who may not be able to join:
For people with DM1 specifically:
- Your DM1 symptoms started before age 20 (known as congenital or childhood-onset DM1)
- You have been diagnosed with dementia, epilepsy/seizures, stroke, multiple sclerosis, Parkinson's disease, or another condition that affects the brain or nervous system
For everyone (DM1, DM2, and healthy volunteers):
- You have a pacemaker, defibrillator, or any metal implant in your body that is not safe to use inside an MRI scanner
- You experience severe anxiety in enclosed spaces (claustrophobia)
- You have been diagnosed with dementia, epilepsy/seizures, stroke, multiple sclerosis, Parkinson's disease, or another condition affecting the brain or nervous system
- You are currently experiencing a significant mental health condition, or have issues with alcohol or substance use
- You have a serious medical condition that would make MRI scanning or movement/strength testing unsafe
- You are taking medications that cause significant drowsiness or affect your thinking, unless you have been on the same dose for at least 3 months before the study visit
- You are currently pregnant
- You weigh more than 400 pounds, as the MRI table may not be able to safely support you
- You are unwilling or unable to give your written agreement to take part
If you take part in a spinal fluid (lumbar puncture) procedure:
- You have taken blood-thinning medications (such as aspirin or similar drugs) within the last 7 days
- You take anticoagulant medications such as warfarin (Coumadin)
- You have a history of bleeding disorders
- Your platelet count (a measure of blood clotting ability) was below 150,000 in the last 6 months
- You have any hardware such as pins, screws, or rods in your lower back area
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measures of voxel-based brain morphometry; Fractional Anisotropy (FA); Radial Diffusivity (RD); Axial Diffusivity (AD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.